Disclosed are novel compounds having the formula
##STR1##
or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds
can be used to modulate (antagonize, agonize) chemokine receptor function. Also
disclosed is a method for treating a patient having an inflammatory disease and/or
viral infection comprising administering an effective amount of a compound of Formula
I. In particular embodiments, the invention is a method for treating a patient
infected with HIV.